A-A-51257
22 December 1985
COMMERIAL ITEM DESCRIPTION
SPONGE, SURGICAL, GAUZE, TONSIL
The General Services Administration has authorized the use of this commercial item description.
This Commercial Item Description covers a ¾ inch (1.90 cm) diameter Tonsil Sponge.
Salient characteristics:
Shall be a nonsterile, radiopaquem double string, medium size tonsil sponge for nasopharyl packing. The sponge shall be spherical in shape having a diameter of 7/8 ± 1/8 inch. The sponge shall be made of tightly compressed Purified Cotton, USP, covered with one layer of type III Absorbent Gauze, USP.
Each sponge shall have two strings attached. Each string shall be a minimum of 15 inches long.
The strings shall not be capable of being pulled out of the sponge. The radiopaque insert shall be visible through the gauze, but shall have no exposed ends. The gauze shall have no exposed raw edges.
Testing and examination shall be conducted to determine compliance with all specification requirements. Test method shall be suitable, accurate and reproducible.
Workmanship. The sponges shall be free from defects which detract from their appearance or impair their serviceability.
Unit. Package (PG). Shall be supplied 5 sponges per envelope. At the manufacturer’s option, the five sponges shall be attached to an accountability card which has a pressure sensitive adhesive backing. One package containing 200 envelopes (1000 sponges), as specified, constitutes one unit.
Contractor certification. The contractor shall certify and maintain substantiating evidence that the product offered meets the salient characteristics of this Commercial Item Description, and that the product conforms to the producers’ own drawings, specifications, standards, and quality assurance practices. The government reserves the right to require proof of such conformance prior to first delivery and thereafter as may be otherwise provided for under the provisions of the contract.
Regulatory requirements.
Federal Food, Drug and Cosmetic Act. If the product covered by this document has been determined by the U.S. Food and Drug Administration to be under its jurisdiction, the offeror/contractor shall comply, and be responsible for compliance by its subcontractors/suppliers, with the requirements of Federal Food, Drug and Cosmetic Act, as amended, and regulations promulgated thereunder. In addition, the offeror/contractor shall comply, and be responsible for compliance by its
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires call Parts Hangar, Inc (727) 493-0744
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business